VU0364572
VU0364572 is a selective allosteric agonist of the M1 muscarinic receptor with an EC50 of 0.11 μM. VU0364572 has neuroprotective potential for preventing memory impairments and reducing neuropathology in Alzheimer’s Disease. VU0364572 is orally active and is CNS penetrant.
For research use only. We do not sell to patients.
- CAS No.: 1240514-87-7
- Formula: C21H31N3O3
- Molecular Weight:373.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | EC50 |
>30 μM
Compound: 17, VU0364572
|
Agonist activity at rat muscarinic M2 receptor expressed in CHO cells
Agonist activity at rat muscarinic M2 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
>30 μM
Compound: 17, VU0364572
|
Agonist activity at rat muscarinic M3 receptor expressed in CHO cells
Agonist activity at rat muscarinic M3 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
>30 μM
Compound: 17, VU0364572
|
Agonist activity at rat muscarinic M4 receptor expressed in CHO cells
Agonist activity at rat muscarinic M4 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
>30 μM
Compound: 17, VU0364572
|
Agonist activity at rat muscarinic M5 receptor expressed in CHO cells
Agonist activity at rat muscarinic M5 receptor expressed in CHO cells
|
[PMID: 21930376] |
| CHO | EC50 |
0.11 μM
Compound: 17, VU0364572
|
Agonist activity at rat muscarinic M1 receptor expressed in CHO cells
Agonist activity at rat muscarinic M1 receptor expressed in CHO cells
|
[PMID: 21930376] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1240514-87-7
-
Molecular Weight 373.49
-
Formula C21H31N3O3
-
SMILES
O=C(N1CCC(N2C[C@H](NC(C3=CC=CC=C3C)=O)CCC2)CC1)OCC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Lebois EP, et al. Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model. ACS Chem Neurosci. 2017 Jun 21;8(6):1177-1187. [Content Brief]
[2]. Faruk MO, et al. Muscarinic signaling regulates voltage-gated potassium channel KCNQ2 phosphorylation in the nucleus accumbens via protein kinase C for aversive learning. J Neurochem. 2022 Feb;160(3):325-341. [Content Brief]
[3]. Lebois EP, et al. Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6451-5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)